These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37641532)

  • 1. Optimizing treatment allocation in randomized clinical trials by leveraging baseline covariates.
    Zhang W; Zhang Z; Liu A
    Biometrics; 2023 Dec; 79(4):2815-2829. PubMed ID: 37641532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning methods for leveraging baseline covariate information to improve the efficiency of clinical trials.
    Zhang Z; Ma S
    Stat Med; 2019 May; 38(10):1703-1714. PubMed ID: 30474289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covariate adjustment in subgroup analyses of randomized clinical trials: A propensity score approach.
    Yang S; Li F; Thomas LE; Li F
    Clin Trials; 2021 Oct; 18(5):570-581. PubMed ID: 34269087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmented generalized estimating equations for improving efficiency and validity of estimation in cluster randomized trials by leveraging cluster-level and individual-level covariates.
    Stephens AJ; Tchetgen Tchetgen EJ; De Gruttola V
    Stat Med; 2012 May; 31(10):915-30. PubMed ID: 22359361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propensity score weighting for covariate adjustment in randomized clinical trials.
    Zeng S; Li F; Wang R; Li F
    Stat Med; 2021 Feb; 40(4):842-858. PubMed ID: 33174296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression analysis for covariate-adaptive randomization: A robust and efficient inference perspective.
    Ma W; Tu F; Liu H
    Stat Med; 2022 Dec; 41(29):5645-5661. PubMed ID: 36134688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomization, matching, and propensity scores in the design and analysis of experimental studies with measured baseline covariates.
    Loux TM
    Stat Med; 2015 Feb; 34(4):558-70. PubMed ID: 25384851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of inverse probability weighting using the propensity score for baseline covariate adjustment in smaller population randomised controlled trials with a continuous outcome.
    Raad H; Cornelius V; Chan S; Williamson E; Cro S
    BMC Med Res Methodol; 2020 Mar; 20(1):70. PubMed ID: 32293286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple, flexible, and effective covariate-adaptive treatment allocation procedure.
    Loux TM
    Stat Med; 2013 Sep; 32(22):3775-87. PubMed ID: 23637002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double Robust Efficient Estimators of Longitudinal Treatment Effects: Comparative Performance in Simulations and a Case Study.
    Tran L; Yiannoutsos C; Wools-Kaloustian K; Siika A; van der Laan M; Petersen M
    Int J Biostat; 2019 Feb; 15(2):. PubMed ID: 30811344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leveraging prognostic baseline variables to gain precision in randomized trials.
    Colantuoni E; Rosenblum M
    Stat Med; 2015 Aug; 34(18):2602-17. PubMed ID: 25872751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression-based multiple treatment effect estimation under covariate-adaptive randomization.
    Gu Y; Liu H; Ma W
    Biometrics; 2023 Dec; 79(4):2869-2880. PubMed ID: 37700503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving causal inference with a doubly robust estimator that combines propensity score stratification and weighting.
    Linden A
    J Eval Clin Pract; 2017 Aug; 23(4):697-702. PubMed ID: 28116816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials.
    Wahed AS; Tsiatis AA
    Biometrics; 2004 Mar; 60(1):124-33. PubMed ID: 15032782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locally efficient estimation of marginal treatment effects when outcomes are correlated: is the prize worth the chase?
    Stephens A; Tchetgen Tchetgen E; De Gruttola V
    Int J Biostat; 2014; 10(1):59-75. PubMed ID: 24566369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing unequal randomization in clinical trials with heterogeneous treatment costs.
    Sverdlov O; Ryeznik Y
    Stat Med; 2019 Jul; 38(16):2905-2927. PubMed ID: 31049999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semiparametric estimation of treatment effect with time-lagged response in the presence of informative censoring.
    Lu X; Tsiatis AA
    Lifetime Data Anal; 2011 Oct; 17(4):566-93. PubMed ID: 21706378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted estimation of nuisance parameters to obtain valid statistical inference.
    van der Laan MJ
    Int J Biostat; 2014; 10(1):29-57. PubMed ID: 24516006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing efficient randomized trials: power and sample size calculation when using semiparametric efficient estimators.
    Schuler A
    Int J Biostat; 2021 Aug; 18(1):151-171. PubMed ID: 34364314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.